Rostama, B.;                     Beauchemin, M.;                     Bouchard, C.;                     Bernier, E.;                     Vary, C.P.H.;                     May, M.;                     Houseknecht, K.L.    
        Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. Int. J. Mol. Sci. 2020, 21, 9362.
    https://doi.org/10.3390/ijms21249362
    AMA Style
    
                                Rostama B,                                 Beauchemin M,                                 Bouchard C,                                 Bernier E,                                 Vary CPH,                                 May M,                                 Houseknecht KL.        
                Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. International Journal of Molecular Sciences. 2020; 21(24):9362.
        https://doi.org/10.3390/ijms21249362
    
    Chicago/Turabian Style
    
                                Rostama, Bahman,                                 Megan Beauchemin,                                 Celeste Bouchard,                                 Elizabeth Bernier,                                 Calvin P. H. Vary,                                 Meghan May,                                 and Karen L. Houseknecht.        
                2020. "Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice" International Journal of Molecular Sciences 21, no. 24: 9362.
        https://doi.org/10.3390/ijms21249362
    
    APA Style
    
                                Rostama, B.,                                 Beauchemin, M.,                                 Bouchard, C.,                                 Bernier, E.,                                 Vary, C. P. H.,                                 May, M.,                                 & Houseknecht, K. L.        
        
        (2020). Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. International Journal of Molecular Sciences, 21(24), 9362.
        https://doi.org/10.3390/ijms21249362